Jeremy J Youngblood is a Kansas City, Missouri based Periodontics who is specialized in Periodontology. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 6301 N Oak Trfy, Suite 102, Kansas City. Patients can reach him at 816-453-2323.
Jeremy J Youngblood is specialized in that branch of dentistry which encompasses the prevention, diagnosis and treatment of diseases of the supporting and surrounding tissues of the teeth or their substitutes and the maintenance of the health, function and esthetics of these structures and tissues.
Complete Profile:
Jeremy J Youngblood speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Jeremy J Youngblood
Specialization:
Periodontics
Gender:
Male
Credentials:
DDS
Accepts Medicare Assignment:
May Accept
Practice Address:
6301 N Oak Trfy, Suite 102, Kansas City, Missouri, 64118-4705
Phone:
816-453-2323
Fax:
816-453-3130
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
1052539079
Enrollment ID:
I20140904000167
NPI Number:
1881813392
NPI Enumeration Date:
24 Apr, 2007
NPI Last Update On:
08 Jul, 2007
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
6301 N Oak Trfy, Suite 102 Kansas City, Missouri
Zip:
64118-4705
Phone Number:
816-453-2323
Fax Number:
816-453-3130
Patients can reach Jeremy J Youngblood at 6301 N Oak Trfy, Suite 102, Kansas City, Missouri or can call to book an appointment on 816-453-2323. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.